RB1 and glioblastoma: Methylation of the RB1 promoter, which is frequent in secondary GBM (IDH-mutant ones), can also result in decreased RB1 expression and cell-cycle checkpoint function and finally leads to dysregulated cell cycle and uncontrolled cell proliferation.